These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 878012)

  • 1. Effects of feeding syngeneic and allogeneic tissues on growth of an allotransplantable tumor.
    Breyere EJ; Heath JR
    Transplant Proc; 1977 Jun; 9(2):1459-63. PubMed ID: 878012
    [No Abstract]   [Full Text] [Related]  

  • 2. Host response to premalignant mammary tissues.
    Slemmer G
    Natl Cancer Inst Monogr; 1972 Dec; 35():57-71. PubMed ID: 4659058
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful murine tumor allotransplantation after total lymphoid irradiation.
    Hoppe RT; Dorie MJ
    J Immunol; 1982 Jun; 128(6):2387-9. PubMed ID: 7042838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple composition of foreign alloantigens on a murine fibrosarcoma [proceedings].
    Invernizzi G; Carbone G; Parmiana G
    Folia Biol (Praha); 1976; 22(6):393-4. PubMed ID: 1001559
    [No Abstract]   [Full Text] [Related]  

  • 6. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 8. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of cyclophosphamide-treated tumor cells.
    Kawalec M; Skórski T; Hoser G
    Arch Immunol Ther Exp (Warsz); 1988; 36(3):345-50. PubMed ID: 3250356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The rate of macrophage inclusion in the elimination of tumor cells when administered to syngeneic animals].
    Lavrovskiĭ VA; Ustinov AS
    Eksp Onkol; 1990; 12(5):35-6. PubMed ID: 2226255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant cell arrest in thymus and spleen of mice bearing transplanted tumors.
    Haran-Ghera N; Krauthgamer R; Peled A
    J Immunol; 1981 Apr; 126(4):1241-4. PubMed ID: 6782158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions.
    Giovarelli M; Musiani P; Garotta G; Ebner R; Di Carlo E; Kim Y; Cappello P; Rigamonti L; Bernabei P; Novelli F; Modesti A; Coletti A; Ferrie AK; Lollini PL; Ruben S; Salcedo T; Forni G
    J Immunol; 1999 Nov; 163(9):4886-93. PubMed ID: 10528190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined treatments with vitamin A and 5-fluorouracil and the growth of allotransplantable and syngeneic tumors in mice.
    Tomita Y; Himeno K; Nomoto K; Endo H; Hirohata T
    J Natl Cancer Inst; 1982 May; 68(5):823-7. PubMed ID: 6951091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are dead cells responsible for allogeneic growth of organ cultures and cell suspensions of BALB/c Leydig cell tumors?
    Jacobs BB
    Transplantation; 1976 May; 21(5):433-6. PubMed ID: 1273915
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenetic control of metastatic competence of cloned tumor cell populations.
    Eisenbach L; De Baetselier P; Katzav S; Segal S; Feldman M
    Symp Fundam Cancer Res; 1983; 36():101-21. PubMed ID: 6332357
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.